Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

$[Refractory vomiting with cisplatin therapy. Prospective study with the serotonin receptor antagonist GR 38032F].$
[Refractory vomiting with cisplatin therapy. Prospective study with the serotonin receptor antagonist GR 38032F].

III study].

Ondansetron and cisplatin-induced nausea and vomiting.

Ondansetron in intractable nausea and vomiting.

The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery.

Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient.

Antiemetic efficacy and pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F) during multiple-day chemotherapy with cisplatin prior to autologous bone marrow transplantation.

Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting.

Ondansetron: a serotonin receptor (5-HT3) antagonist for antineoplastic chemotherapy-induced nausea and vomiting.

[Prevention of postoperative nausea and vomiting by ondansetron].

Prevention of postoperative nausea and vomiting: a thought on ondansetron.

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.

Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron.

The role of 5-HT in postoperative nausea and vomiting.

Ondansetron: a review of pharmacokinetics and clinical experience in postoperative nausea and vomiting.

Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department.

Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist.

Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients.

Postoperative Nausea and Vomiting: Palonosetron with Dexamethasone vs. Ondansetron with Dexamethasone in Laparoscopic Hysterectomies.

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.

Postoperative nausea and vomiting.

Suggest Documents

[Refractory vomiting with cisplatin therapy. Prospective study with the serotonin receptor antagonist GR 38032F].

III study].

Ondansetron and cisplatin-induced nausea and vomiting.

Ondansetron in intractable nausea and vomiting.

The efficacy of ginger added to ondansetron for preventing postoperative nausea and vomiting in ambulatory surgery.

Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient.

Antiemetic efficacy and pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F) during multiple-day chemotherapy with cisplatin prior to autologous bone marrow transplantation.

Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting.

Ondansetron: a serotonin receptor (5-HT3) antagonist for antineoplastic chemotherapy-induced nausea and vomiting.

[Prevention of postoperative nausea and vomiting by ondansetron].

Prevention of postoperative nausea and vomiting: a thought on ondansetron.

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.

Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron.

The role of 5-HT in postoperative nausea and vomiting.

Ondansetron: a review of pharmacokinetics and clinical experience in postoperative nausea and vomiting.

Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department.

Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist.

Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients.

Postoperative Nausea and Vomiting: Palonosetron with Dexamethasone vs. Ondansetron with Dexamethasone in Laparoscopic Hysterectomies.

A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.

Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.

Postoperative nausea and vomiting.

Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Recommend Documents

Follow Us